Market Closed -
Other stock markets
|
Pre-market 08:16:38 am | |||
314.7 USD | -1.35% | 315.8 | +0.33% |
01:09am | US FDA approves Amgen drug for small cell lung cancer | RE |
May. 16 | Amgen Gets FDA Approval for Small-Cell Lung-Cancer Treatment | DJ |
Evolution of the average Target Price on Amgen Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Amgen Inc.
Redburn Atlantic | |
Mizuho Securities | |
UBS | |
Deutsche Bank Securities | |
William Blair & Co. | |
Leerink Partners | |
Barclays | |
Morgan Stanley | |
RBC Capital Markets | |
BMO Capital | |
Goldman Sachs | |
TD Cowen | |
Oppenheimer | |
Baird | |
Daiwa Securities | |
Truist Securities | |
Argus | |
HSBC | |
Jefferies & Co. | |
Credit Suisse | |
DA Davidson | |
Piper Sandler | |
Wells Fargo Securities | |
SVB Securities LLC | |
Cowen | |
Atlantic Equities | |
BofA Securities | |
SVB Leerink | |
JPMORGAN | Cory Kasimov |
RBC | Kennen Mackay |
EPS Revisions
- Stock Market
- Equities
- AMGN Stock
- Consensus Amgen Inc.